GLUEMonte Rosa Therapeutics, Inc.Mar 20, 2025Q4 2024
Read transcript →Monte Rosa Therapeutics, Inc. (GLUE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$11.91
-5.48%
Mkt Cap $1.07B
GLUEMonte Rosa Therapeutics, Inc.Mar 20, 2025GLUEMonte Rosa Therapeutics, Inc.Mar 20, 2025